December 28, 2010

Use of Hydroxychloroquine Benefits Sugar Metabolism in Women With Lupus

From our latest Research Update Newsletter:
Hydroxychloroquine (Plaquenil) is in a class of drugs that was originally developed to treat malaria and has been considered to be a safe and effective treatment for mild lupus and rheumatoid arthritis (RA) since 1957. Low blood sugar is an occasional side effect of taking these anti-malarial drugs, but how this happens is not well understood.  The researchers hoped to learn whether there are any tests that could predict low blood sugar in women with lupus taking hydroxychloroquine.

Read more

Want to read these summaries earlier? Sign up for our newsletters here.

No comments: